Burgess Daniel D
- SEC CIK
- 0001239650
No open-market purchases or sales filed in the past year.
Current role at each company
- CDTX Cidara Therapeutics, Inc.Directoras of Jan 7, 2026
- ABUS Arbutus Biopharma CorpDirectoras of May 24, 2024
- Nabriva Therapeutics plcDirectoras of Aug 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Burgess Daniel D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Nabriva Therapeutics plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 (view filing)6:24 PM ET | Aug 2 | 2 days | Burgess Daniel DDirector | SSale | −11.3K | $0.1901 | −$2.16K | −52.2%10.4K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Burgess Daniel DDirector | SSale | −1.13K | $1.20 | −$1.35K | −4.9%21.7K after |